Trials / Completed
CompletedNCT01476995
Prognostic Indicators as Provided by the EPIC ClearView
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 353 (actual)
- Sponsor
- Epic Research & Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with known diagnoses identified by medical doctors. Specifically, the investigators hypothesize that the organ system involving any of a series of known active diagnoses will be identified in the EPIC ClearView Response Scale report with the intention of providing potential triage capabilities.
Conditions
- Coronary Artery Disease
- Congestive Heart Failure
- Valvular Heart Disease
- Atrial Fibrillation
- Hypertension
- Pyelonephritis
- Acute Renal Failure
- Renal Failure
- Viral Hepatitis
- Alcoholic Hepatitis
- Steatohepatitis
- Cirrhosis
- Asthma
- COPD
- Bronchitis
- Emphysema
- Pneumonia
- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis
- Diverticulitis
- Peptic Ulcer Disease
- Irritable Bowel Syndrome
- Cholecystitis
- Pancreatitis
- Malabsorption Disorders
- Celiac Sprue
- Diabetes
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2011-11-22
- Last updated
- 2011-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01476995. Inclusion in this directory is not an endorsement.